Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Draper

Showing results (21-30 of 165) with videos related to

Pageof 17
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2011
Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interferenceEmily K Forbes, Sumi Biswas, Katharine A Collins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2005
Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominanceAnne C Moore, Awen Gallimore, Simon J Draper, et al.
Plos One|January 5, 2012
A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activityAnna L Goodman, Andrew M Blagborough, Sumi Biswas, et al.
Malaria Journal|December 15, 2019
Use of gene expression studies to investigate the human immunological response to malaria infectionSusanne H Hodgson, Julius Muller, Helen E Lockstone, et al.
BMC Medicine|January 31, 2019
Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposureVictor Yman, Michael T White, Muhammad Asghar, et al.
Biomaterials|May 12, 2026
Harnessing prophylactic vaccines for targeted cancer immunotherapy by phage-guided delivery of cognate antigens to tumorsSajee Waramit, Keittisak Suwan, Alara Küçük, et al.
Vaccine|October 13, 2010
Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1Alexander D Douglas, Simone C de Cassan, Matthew D J Dicks, et al.
Elife|October 5, 2023
Erythrocyte invasion-neutralising antibodies prevent <i>Plasmodium falciparum</i> RH5 from binding to basigin-containing membrane protein complexesAbhishek Jamwal, Cristina F Constantin, Stephan Hirschi, et al.
Vaccine|October 18, 2015
Progress with viral vectored malaria vaccines: A multi-stage approach involving "unnatural immunity"Katie J Ewer, Kailan Sierra-Davidson, Ahmed M Salman, et al.
Cell Host & Microbe|January 22, 2009
Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malariaSimon J Draper, Anna L Goodman, Sumi Biswas, et al.
Pageof 17

Showing results (21-30 of 165) with videos related to

Sort By:
Pageof 17
Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2011
Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interferenceEmily K Forbes, Sumi Biswas, Katharine A Collins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2005
Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominanceAnne C Moore, Awen Gallimore, Simon J Draper, et al.
Plos One|January 5, 2012
A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activityAnna L Goodman, Andrew M Blagborough, Sumi Biswas, et al.
Malaria Journal|December 15, 2019
Use of gene expression studies to investigate the human immunological response to malaria infectionSusanne H Hodgson, Julius Muller, Helen E Lockstone, et al.
BMC Medicine|January 31, 2019
Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposureVictor Yman, Michael T White, Muhammad Asghar, et al.
Biomaterials|May 12, 2026
Harnessing prophylactic vaccines for targeted cancer immunotherapy by phage-guided delivery of cognate antigens to tumorsSajee Waramit, Keittisak Suwan, Alara Küçük, et al.
Vaccine|October 13, 2010
Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1Alexander D Douglas, Simone C de Cassan, Matthew D J Dicks, et al.
Elife|October 5, 2023
Erythrocyte invasion-neutralising antibodies prevent <i>Plasmodium falciparum</i> RH5 from binding to basigin-containing membrane protein complexesAbhishek Jamwal, Cristina F Constantin, Stephan Hirschi, et al.
Vaccine|October 18, 2015
Progress with viral vectored malaria vaccines: A multi-stage approach involving "unnatural immunity"Katie J Ewer, Kailan Sierra-Davidson, Ahmed M Salman, et al.
Cell Host & Microbe|January 22, 2009
Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malariaSimon J Draper, Anna L Goodman, Sumi Biswas, et al.
Pageof 17